News from aratana therapeutics A wide array of domestic and global news stories; news topics include politics / government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle. Articles that appear in this section may be written in English or other languages, as well.

Sep 18, 2014, 18:30 ET

Aratana Therapeutics, Inc. Announces Full Exercise of Underwriters' Option to Purchase Additional Shares

 Aratana Therapeutics, Inc. (NASDAQ: PETX), a pet therapeutics company focused on licensing, developing and commercializing innovative...

Sep 17, 2014, 09:20 ET

Aratana Therapeutics, Inc. Announces Pricing of Public Offering

 Aratana Therapeutics, Inc. (NASDAQ: PETX), a pet therapeutics company focused on licensing, developing and commercializing innovative...

Sep 16, 2014, 16:01 ET

Aratana Therapeutics, Inc. Announces Proposed Public Offering

 Aratana Therapeutics, Inc. (NASDAQ: PETX), a pet therapeutics company focused on licensing, developing and commercializing innovative...

Sep 09, 2014, 07:00 ET

Aratana Therapeutics Reports Positive Effectiveness Data from Pilot Field Study of Bupivacaine Extended-Release Injectable Suspension (AT-003)

 Aratana Therapeutics, Inc. (NASDAQ: PETX), a pet therapeutics company focused on licensing, developing and commercializing innovative...

Sep 05, 2014, 08:15 ET

Aratana Therapeutics to Present at Morgan Stanley Global Healthcare Conference

 Aratana Therapeutics, Inc. (NASDAQ: PETX), a pet therapeutics company focused on licensing, developing and commercializing innovative...

Aug 12, 2014, 06:30 ET

Aratana Therapeutics Reports Second Quarter 2014 Results

 Aratana Therapeutics, Inc. (NASDAQ: PETX), a pet therapeutics company focused on licensing, developing and commercializing innovative...

Aug 07, 2014, 17:52 ET

Aratana Therapeutics Appoints Irvine Hockaday to Board of Directors

 Aratana Therapeutics, Inc. (NASDAQ: PETX), a pet therapeutics company focused on licensing, developing and commercializing innovative...

Aug 07, 2014, 15:28 ET

Aratana Therapeutics Inc. to Report Second Quarter Financial Results

 Aratana Therapeutics, Inc. (Nasdaq: PETX), a pet therapeutics company focused on licensing, developing and commercializing innovative...

Jul 02, 2014, 07:30 ET

Aratana Therapeutics Files for USDA Product License of AT-014 Canine Osteosarcoma Immunotherapy

 Aratana Therapeutics, Inc. (NASDAQ: PETX), a pet therapeutics company focused on licensing, developing and commercializing innovative...

Jun 23, 2014, 16:01 ET

Aratana Therapeutics Adds Robert P. Roche, Jr. to Board of Directors

 Aratana Therapeutics, Inc. (NASDAQ: PETX), a pet therapeutics company focused on the licensing, development and commercialization of...

Jun 19, 2014, 16:31 ET

Aratana Therapeutics to Participate in Two Upcoming Investor Conferences

 Aratana Therapeutics, Inc. (NASDAQ: PETX), a pet therapeutics company focused on licensing, developing and commercializing innovative...

Jun 18, 2014, 16:15 ET

Aratana Therapeutics Initiates and Doses First Patient in Market Development Studies of AT-005 for Treating Canine T-cell Lymphoma

KANSAS CITY, Kan., June 18, 2014 /PRNewswire/ -- Aratana Therapeutics, Inc. (NASDAQ: PETX), a pet therapeutics company focused on...

Jun 12, 2014, 18:45 ET

Aratana Therapeutics Expands Pain Franchise with Novel Regenerative Cell Therapy for Treating Osteoarthritis

 Aratana Therapeutics, Inc. (NASDAQ: PETX), a pet therapeutics company focused on licensing, developing and commercializing innovative...

Jun 09, 2014, 08:09 ET

Aratana Therapeutics Presents Safety and Clinical Findings at 2014 ACVIM Forum

Aratana Therapeutics, Inc. (NASDAQ: PETX), a pet therapeutics company focused on licensing, developing and commercializing innovative...

May 30, 2014, 08:14 ET

Aratana Therapeutics to Participate in Upcoming Investor Conferences

 Aratana Therapeutics, Inc. (NASDAQ: PETX), a pet therapeutics company focused on licensing, developing and commercializing innovative...

May 23, 2014, 09:56 ET

Aratana Therapeutics to Participate in Two Upcoming Investor Conferences

Aratana Therapeutics, Inc. (NASDAQ: PETX), a pet therapeutics company focused on licensing, developing and commercializing innovative...

May 13, 2014, 16:01 ET

Aratana Therapeutics Reports First Quarter 2014 Results

 Aratana Therapeutics, Inc. (NASDAQ: PETX), a pet therapeutics company focused on licensing, developing and commercializing innovative...

May 12, 2014, 07:30 ET

Aratana Therapeutics Initiates Pivotal Study for AT-001

 Aratana Therapeutics, Inc. (NASDAQ: PETX), a pet therapeutics company focused on the licensing, development and commercialization of...

May 05, 2014, 07:30 ET

Aratana Therapeutics Inc. to Report First Quarter Financial Results

Aratana Therapeutics, Inc. (Nasdaq: PETX), a pet therapeutics company focused on the licensing, development and commercialization of innovative...

May 02, 2014, 07:30 ET

Aratana Therapeutics to Present at 2014 ACVIM Forum

 Aratana Therapeutics, Inc. (NASDAQ: PETX), a pet therapeutics company focused on the licensing, development and commercialization of...